BUSERELIN , 99.9% , 57982-77-1
CAS NO.：57982-77-1
Empirical Formula: C60H86N16O13
Molecular Weight: 1239.42
MDL number: MFCD00870371
PRODUCT Properties
| alpha | D20 -40.4° (c = 1 in dimethylacetamide) |
| Boiling point: | 845.19°C (rough estimate) |
| Density | 1.0711 (rough estimate) |
| refractive index | 1.6200 (estimate) |
| solubility | Sparingly soluble in water and in dilute acids. |
| pka | 9.82±0.15(Predicted) |
| form | Solid |
| color | White to Off-White |
| Stability: | Hygroscopic |
| InChIKey | CUWODFFVMXJOKD-UHFFFAOYSA-N |
Description and Uses
Buserelin (Suprefact?) is a hormonal therapy drug used to treat advanced prostate cancer. It is a medication which is used primarily in the treatment of prostate cancer and endometriosis. It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy. In addition, buserelin is used in veterinary medicine. The medication is typically used as a nasal spray three times per day, but is also available for use as a solution or implant for injection into fat.
Gonad-stimulating principle.
Safety
| Symbol(GHS) |   GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302-H360F |
| Precautionary statements | P308+P313 |
| HS Code | 2937190000 |
